Microginin 761B
| Internal ID | c2e562bd-3f0a-41e9-94ae-e050745c4168 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | 2-[[2-[[1-[2-[(3-amino-10-chloro-2-hydroxydecanoyl)amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C37H52ClN5O10/c1-22(44)31(42-35(50)32(47)27(39)8-5-3-2-4-6-18-38)36(51)43-19-7-9-30(43)34(49)40-28(20-23-10-14-25(45)15-11-23)33(48)41-29(37(52)53)21-24-12-16-26(46)17-13-24/h10-17,22,27-32,44-47H,2-9,18-21,39H2,1H3,(H,40,49)(H,41,48)(H,42,50)(H,52,53) |
| InChI Key | NWKXLGDOMIUDOE-UHFFFAOYSA-N |
| Popularity | 3 references in papers |
| Molecular Formula | C37H52ClN5O10 |
| Molecular Weight | 762.30 g/mol |
| Exact Mass | 761.3402706 g/mol |
| Topological Polar Surface Area (TPSA) | 252.00 Ų |
| XlogP | 0.30 |
| Atomic LogP (AlogP) | 1.06 |
| H-Bond Acceptor | 10 |
| H-Bond Donor | 9 |
| Rotatable Bonds | 21 |
| DTXSID501046959 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6084 | 60.84% |
| Caco-2 | - | 0.8911 | 89.11% |
| Blood Brain Barrier | - | 0.8500 | 85.00% |
| Human oral bioavailability | - | 0.7429 | 74.29% |
| Subcellular localzation | Mitochondria | 0.5438 | 54.38% |
| OATP2B1 inhibitior | + | 0.5603 | 56.03% |
| OATP1B1 inhibitior | + | 0.8910 | 89.10% |
| OATP1B3 inhibitior | + | 0.9344 | 93.44% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.8750 | 87.50% |
| BSEP inhibitior | + | 0.8383 | 83.83% |
| P-glycoprotein inhibitior | + | 0.7207 | 72.07% |
| P-glycoprotein substrate | + | 0.7633 | 76.33% |
| CYP3A4 substrate | + | 0.7097 | 70.97% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.7774 | 77.74% |
| CYP3A4 inhibition | + | 0.5061 | 50.61% |
| CYP2C9 inhibition | - | 0.8692 | 86.92% |
| CYP2C19 inhibition | - | 0.7956 | 79.56% |
| CYP2D6 inhibition | - | 0.8636 | 86.36% |
| CYP1A2 inhibition | - | 0.8889 | 88.89% |
| CYP2C8 inhibition | + | 0.5000 | 50.00% |
| CYP inhibitory promiscuity | - | 0.8187 | 81.87% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8100 | 81.00% |
| Carcinogenicity (trinary) | Non-required | 0.5525 | 55.25% |
| Eye corrosion | - | 0.9904 | 99.04% |
| Eye irritation | - | 0.9173 | 91.73% |
| Skin irritation | - | 0.7657 | 76.57% |
| Skin corrosion | - | 0.9367 | 93.67% |
| Ames mutagenesis | - | 0.6900 | 69.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6995 | 69.95% |
| Micronuclear | + | 0.8900 | 89.00% |
| Hepatotoxicity | + | 0.5459 | 54.59% |
| skin sensitisation | - | 0.8864 | 88.64% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 1.0000 | 100.00% |
| Mitochondrial toxicity | + | 0.8875 | 88.75% |
| Nephrotoxicity | - | 0.7648 | 76.48% |
| Acute Oral Toxicity (c) | III | 0.6543 | 65.43% |
| Estrogen receptor binding | + | 0.8278 | 82.78% |
| Androgen receptor binding | + | 0.7247 | 72.47% |
| Thyroid receptor binding | + | 0.5274 | 52.74% |
| Glucocorticoid receptor binding | + | 0.6094 | 60.94% |
| Aromatase binding | + | 0.5512 | 55.12% |
| PPAR gamma | + | 0.7346 | 73.46% |
| Honey bee toxicity | - | 0.8579 | 85.79% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.5581 | 55.81% |
| Fish aquatic toxicity | + | 0.8935 | 89.35% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.69% | 98.95% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 99.24% | 93.10% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.68% | 96.09% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.42% | 100.00% |
| CHEMBL3837 | P07711 | Cathepsin L | 98.39% | 96.61% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 97.74% | 83.82% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.15% | 98.33% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.83% | 94.45% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 96.68% | 96.67% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 94.93% | 93.56% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 94.30% | 99.17% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 93.59% | 90.71% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 93.12% | 95.17% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 92.82% | 95.89% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 92.00% | 95.52% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 91.99% | 91.11% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.98% | 100.00% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 90.77% | 98.24% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 90.68% | 100.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.57% | 97.09% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 90.18% | 95.56% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 89.64% | 97.23% |
| CHEMBL4198 | P98170 | Inhibitor of apoptosis protein 3 | 89.51% | 97.79% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.64% | 93.00% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 88.33% | 96.67% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 88.22% | 97.64% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 87.68% | 95.89% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 87.61% | 96.03% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 87.32% | 90.20% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 87.17% | 90.08% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 86.85% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 86.46% | 91.19% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 86.34% | 89.63% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 84.87% | 93.99% |
| CHEMBL1907599 | P05556 | Integrin alpha-4/beta-1 | 84.14% | 92.86% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 83.92% | 90.17% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 83.64% | 97.14% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 83.48% | 85.00% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 81.99% | 99.17% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 81.20% | 90.00% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 81.07% | 95.00% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 80.97% | 94.00% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 80.73% | 83.14% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 80.37% | 94.33% |
| CHEMBL1978 | P11511 | Cytochrome P450 19A1 | 80.16% | 91.76% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146684933 |
| LOTUS | LTS0126211 |
| wikiData | Q104246237 |